April 2025 in “International Journal of Homoeopathic Sciences” This case report suggests that individualized homeopathic therapy with Carcinosin may benefit pediatric patients with alopecia areata by improving hair regrowth and psychological symptoms, as supported by standardized assessment tools.
4 citations
,
January 2017 in “The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology” Gagamhwajung-hwan may effectively treat severe alopecia areata.
July 2024 in “Medical alphabet” This study found that the SBN system effectively evaluates and describes the severity and clinical variant of alopecia areata using a standardized scale, aiding in patient management and disease course prediction.
January 2018 in “Figshare” This study found that both ruxolitinib and tofacitinib were effective in promoting hair regrowth for patients with severe alopecia areata, with no significant difference in efficacy and relapse rate between them, and both were well tolerated throughout the treatment.
April 2026 in “Academic Dermatology” In this retrospective observational study, researchers found that the Dean Scale showed better diagnostic accuracy than the CTCAE scale for detecting clinician-reported therapeutic responses to minoxidil in patients with anticancer therapy-induced alopecia, but both scales had limitations in recording clinically significant hair regrowth.